71 related articles for article (PubMed ID: 3623651)
1. HLA & surface markers in untreated lymphoid leukaemia patients.
Mehta MM; Contractor NM; Advani SH; Bhatia HM
Indian J Med Res; 1987 Apr; 85():415-9. PubMed ID: 3623651
[No Abstract] [Full Text] [Related]
2. Anomalous phenotype in thymic acute lymphoblastic leukaemia.
Bradstock KF; Janossy G; Bollum FJ; Milstein C
Nature; 1980 Apr; 284(5755):455-7. PubMed ID: 6928507
[No Abstract] [Full Text] [Related]
3. Heavy HLA-DR (Ia) antigen chain is controlled by the MHC region.
Klareskog L; Rask L; Fohlman J; Peterson PA
Nature; 1978 Oct; 275(5682):762-4. PubMed ID: 81469
[No Abstract] [Full Text] [Related]
4. HLA-A,B and DR antigens in chronic lymphocytic leukaemia.
Dyer PA; Ridway JC; Flanagan NG
Dis Markers; 1986 Oct; 4(3):231-7. PubMed ID: 3482989
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to human cell surface antigens.
Brown G; Joshua DE; Bastin J; Mason DY; Barnstable CJ
Haematol Blood Transfus; 1979; 23():365-8. PubMed ID: 296113
[No Abstract] [Full Text] [Related]
6. [HLA antigens in patients with acute leukemia].
Prazák J
Cas Lek Cesk; 1988 Apr; 127(14):430-2. PubMed ID: 3164647
[No Abstract] [Full Text] [Related]
7. Histocompatibility antigens (HLA) in acute lymphocytic leukemia.
Ulukutlu L; Yazici H; Cam H; Esen E; Ozbakir F
Turk J Pediatr; 1986; 28(2):111-4. PubMed ID: 3461609
[No Abstract] [Full Text] [Related]
8. Antigenic characteristics of normal and malignant human hematopoietic cells. Potential use of antigenic differences in cell separation and marrow transplantation.
Cline MJ; Fitchen JH; Foon K; Billing R
Exp Hematol; 1979; 7 Suppl 5():246-51. PubMed ID: 400688
[TBL] [Abstract][Full Text] [Related]
9. Correlation of HLA-DRw3 with childhood acute lymphocytic leukemia.
Michel K; Hubbel C; Dock NL; Davey FR
Arch Pathol Lab Med; 1981 Oct; 105(10):560. PubMed ID: 6945072
[No Abstract] [Full Text] [Related]
10. Lymphocyte surface markers profile in acute lymphoblastic leukaemia.
Mehta MM; Contractor NM; Gopal R; Advani SH; Thiel E; Thierfelder S; Bhatia HM
Indian J Med Res; 1987 Sep; 86():329-34. PubMed ID: 3323042
[No Abstract] [Full Text] [Related]
11. Surface phenotype and clinical stages in B-cell chronic lymphocytic leukaemia.
Orfao A; Gonzalez M; San Miguel JF; Moro MJ; Fernandez-Calvo J; Carnero M; Galindo P; Lopez Borrasca A
Haematologica; 1987; 72(1):39-43. PubMed ID: 3108093
[No Abstract] [Full Text] [Related]
12. Clinical usefulness of immunological marker analysis in adult patients with acute leukaemia.
Van 't Veer MB; Tetteroo PA; Von dem Borne KR; Engelfriet CP
Neth J Med; 1985; 28(3):124-7. PubMed ID: 3856755
[No Abstract] [Full Text] [Related]
13. Significance of number of HLA determinants in HLA capping in childhood acute lymphoblastic leukemia.
Hogeman PH; Veerman AJ; Philippus E; Huismans DR; van Zantwijk CH; Bezemer PD
Acta Haematol; 1985; 73(4):196-200. PubMed ID: 2414955
[TBL] [Abstract][Full Text] [Related]
14. [Abnormal phenotype of a chronic lymphatic leukemia: presence of T and B markers defined by monoclonal antibodies].
Gómez Morales M; De Andrés MA; Garrido ML; Delgado C; Cabrera A; Garrido F
Sangre (Barc); 1985; 30(3):348-54. PubMed ID: 3929410
[No Abstract] [Full Text] [Related]
15. Familiar B-cell neoplasms and HLA antigens.
Nigro M; De Rosa G; Camera A; Minerva A; Venuta S; Rotoli B
Haematologica; 1985; 70(5):465. PubMed ID: 3937792
[No Abstract] [Full Text] [Related]
16. [Distribution of leukemia-associated antigens (CALLA, P24 antigen and P20 antigen) on childhood acute lymphoblastic leukemia cells and nonhematopoietic tissues].
Ochiai J; Komada Y; Shimizu K; Kamiya H; Sakurai M
Rinsho Ketsueki; 1987 Sep; 28(9):1522-7. PubMed ID: 2963922
[No Abstract] [Full Text] [Related]
17. HLA antigens and childhood acute lymphocytic leukaemia.
Davey FR; Lachant NA; Dock NL; Hubbell C; Stockman JA; Henry JB
Br J Haematol; 1981 Feb; 47(2):211-20. PubMed ID: 6937215
[TBL] [Abstract][Full Text] [Related]
18. HLA and cancer.
Hors J; Andrieu JM; Gony J
Transplant Proc; 1984 Apr; 16(2):455-7. PubMed ID: 6586006
[No Abstract] [Full Text] [Related]
19. Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate.
Guy K; Meehan RR; Dewar AE; Larhammar D
Immunology; 1986 Feb; 57(2):181-8. PubMed ID: 3512424
[TBL] [Abstract][Full Text] [Related]
20. Surface immunoglobulin intensivity and p67 (CD5) antigen expression define different forms of B-cell chronic lymphocytic leukaemia.
Bassan R; Pronesti M; Buzzetti M; Viero P; Minetti B; Comotti B; Buelli M; Barbui T
Haematologica; 1987; 72(3):221-5. PubMed ID: 3114087
[No Abstract] [Full Text] [Related]
[Next] [New Search]
